The U.S. Food and Drug Administration (FDA) is planning to require all new vaccines to undergo placebo-controlled trials ...

The Melbourne-based company says it has landed one of the biggest licensing deals in Australian biotech history.

Key Takeaways Ozempic/Wegovy can help people with fatty liver diseasePeople on the drug had less liver inflammation and ...

PYRUKYND Net Revenue of $8.7 Million in Q1; Cash, Cash Equivalents and Marketable Securities of $1.4 Billion as of March 31, 2025 - CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Agios ...